ArticleJournal of Cancer2021

A novel risk-scoring system conducing to chemotherapy decision for patients with pancreatic ductal adenocarcinoma after pancreatectomy.

Yuqiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.